GB0608272D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB0608272D0
GB0608272D0 GBGB0608272.1A GB0608272A GB0608272D0 GB 0608272 D0 GB0608272 D0 GB 0608272D0 GB 0608272 A GB0608272 A GB 0608272A GB 0608272 D0 GB0608272 D0 GB 0608272D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0608272.1A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB0608272.1A priority Critical patent/GB0608272D0/en
Publication of GB0608272D0 publication Critical patent/GB0608272D0/en
Priority to JP2009507067A priority patent/JP2009534443A/ja
Priority to EP07728463A priority patent/EP2016061A1/fr
Priority to PCT/EP2007/054007 priority patent/WO2007122241A1/fr
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/48—Nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB0608272.1A 2006-04-26 2006-04-26 Compounds Ceased GB0608272D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GBGB0608272.1A GB0608272D0 (en) 2006-04-26 2006-04-26 Compounds
JP2009507067A JP2009534443A (ja) 2006-04-26 2007-04-24 Ａｍｐａ受容体を増強する化合物および医薬におけるその使用
EP07728463A EP2016061A1 (fr) 2006-04-26 2007-04-24 Composés induisant la potentialisation du récepteur ampa et leurs applications en médecine
PCT/EP2007/054007 WO2007122241A1 (fr) 2006-04-26 2007-04-24 Composés induisant la potentialisation du récepteur ampa et leurs applications en médecine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0608272.1A GB0608272D0 (en) 2006-04-26 2006-04-26 Compounds

Publications (1)

Publication Number Publication Date
GB0608272D0 true GB0608272D0 (en) 2006-06-07

Family

ID=36589865

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0608272.1A Ceased GB0608272D0 (en) 2006-04-26 2006-04-26 Compounds

Country Status (4)

Country Link
EP (1) EP2016061A1 (fr)
JP (1) JP2009534443A (fr)
GB (1) GB0608272D0 (fr)
WO (1) WO2007122241A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0721094D0 (en) * 2007-10-26 2007-12-05 Glaxo Group Ltd Compounds
GB0721092D0 (en) * 2007-10-26 2007-12-05 Glaxo Group Ltd Compounds
CN102127032B (zh) * 2011-01-20 2013-03-06 北京大学 一种多取代5-酰基-2-亚胺噻唑啉的合成方法
CN104918935B (zh) 2012-11-16 2017-07-28 百时美施贵宝公司 二氢吡唑gpr40调节剂
CN105130923A (zh) * 2015-10-13 2015-12-09 浙江工业大学 一种多取代2-亚氨基噻唑类化合物的制备方法
CN114222732B (zh) * 2019-10-28 2023-04-04 南京明德新药研发有限公司 一种尿酸促排剂及其合成方法和其在医药上的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL287940A (fr) * 1962-01-19
JPS57197218A (en) * 1981-05-29 1982-12-03 Nippon Soda Co Ltd Central nervous system depressant containing thiazoline- 5-carboxylic acid derivative

Also Published As

Publication number Publication date
WO2007122241A1 (fr) 2007-11-01
EP2016061A1 (fr) 2009-01-21
JP2009534443A (ja) 2009-09-24

Similar Documents

Publication Publication Date Title
GB0602424D0 (en) Compounds
GB0602046D0 (en) Compounds
GB0605786D0 (en) Compounds
GB0606876D0 (en) Compounds
GB0607175D0 (en) Compounds
GB0605784D0 (en) Compounds
GB0605785D0 (en) Compounds
EP2082022A4 (fr) Composés
GB0608272D0 (en) Compounds
GB0606913D0 (en) Compounds
EP2004174A4 (fr) Composés de naphtalènedione
GB0602042D0 (en) Compounds
EP1973905A4 (fr) Composes
AP2009004767A0 (en) Cubstituted azolin-2-yl-amino compounds
EP2016069A4 (fr) Composé de bis-pyridine
GB0602560D0 (en) Compounds
GB0602412D0 (en) Compounds
GB0600427D0 (en) Compounds
GB0604377D0 (en) Compounds
GB0602559D0 (en) Compounds
GB0605467D0 (en) Compounds
GB0605414D0 (en) Compounds
GB0605412D0 (en) Compounds
GB0605410D0 (en) Compounds
GB0603132D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)